Efficacy of a Microalgae Extract PhaeoSOL Combined With Natural Stimulant on Cognitive Function and Gaming Performance of Video Gamers
PHAEOSOL-TWO
1 other identifier
interventional
60
1 country
1
Brief Summary
Considering the important growing development of gaming in the world, this research area has developed considerably over the last few years. Even if it seems to be well admitted that video gamers showed better cognitive functions (e.g. visual selective attention, cognitive flexibility, task switching) parameters compared to non video gamers there is a constant concern for optimizing performance as for all other kind of athletes. However to our knowledge, only one randomized controlled trial have investigated the potential benefits of dietary supplementation on cognitive function and performance in video gamers. The use of microalgea as molecule of interest sources is a recent promising approach also to meet societal challenge as the maintain of biodiversity/landscape. Thus, the purpose of this study is to examine whether acute (single-dose) and chronic (1 month) supplementation of Microphyt's phaeosol ingredients (BrainPhyt) ingested with or without a natural stimulant, would affect cognitive function and gaming performance in experienced video gamers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2021
CompletedFirst Posted
Study publicly available on registry
April 21, 2021
CompletedStudy Start
First participant enrolled
April 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedSeptember 23, 2022
September 1, 2022
1.1 years
April 15, 2021
September 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Reaction time
Change in reaction time - Light tracking test
From week 0 to week 4
General attention
Change in general attention score - Go no go task test
From week 0 to week 4
Sustained attention
Change in sustained attention score - Psychomotor vigilance task test
From week 0 to week 4
Attention shifting
Change in attention shifting score - Berg-Washington card sorting task test
From week 0 to week 4
Secondary Outcomes (5)
Gaming performance
From week 0 to week 4
Mood state
From week 0 to week 4
Sleep quality
From week 0 to week 4
Eyes irritability
From week 0 to week 4
Global fatigue
From week 0 to week 4
Study Arms (3)
Low dose Phaeosol group
EXPERIMENTAL1 Phaeosol softgel of 440mg/day and 1 placebo softgel of 440mg/day look like softgel of Phaeosol product) + 1 capsule of 440mg/day of natural stimulant
High dose Phaeosol group
EXPERIMENTAL2 Phaeosol softgels of 440mg/day + 1 capsule of 440mg/day of natural stimulant
Placebo group
PLACEBO COMPARATOR2 placebo softgels of 440mg/day (look like softgel of Phaeosol product) + 1 capsule of 440mg/day containing Microcellulose (look like capsule of natural stimulant)
Interventions
1 Phaeosol softgel of 440mg/day and 1 placebo softgel of 500mg/day (look like softgel of Phaeosol product) + 1 capsule of 440mg/day of natural stimulant Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
2 Phaeosol softgels of 440mg/day + 1 capsule of 440mg/day of natural stimulant. Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
2 placebo softgels of 440mg/day (look like softgel of Phaeosol product) + 1 capsule of 500mg/day containing Microcellulose (look like capsule of natural stimulant). Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
Eligibility Criteria
You may qualify if:
- Healthy men and women;
- Between 18 and 40 years;
- Self-reported history of playing video games for 5 or more hours per week for 6 months prior to screening;
- BMI between 18 and 34.9 Kg/m2 ;
- Subjects agreed to supply their own operator-oriented action or strategy video game that they had played at least 21 times over the last 3 months;
- No recent ingestion (\<2weeks) of dietary supplement that affect cognitive function;
- Be able to give written informed consent and to consume the investigational product daily for the duration of the study;
- Is free-living (living in a private home, alone or with family, and able to maintain their health and hygiene without assistance)
- Willing to maintain consistent sleep duration the evening before study visits.
- Are agreed to continue their patterned use of the game between study visits
You may not qualify if:
- refrain from caffeine and alcohol for 12 hours prior to each study visits;
- consume dietary supplements that may affect cognition and/or with a stimulant effect (e.g. guarana, cocoa, ginseng, bacopa, Gingko biloba, guayusa, yerba mate, energy drinks, other products containing fucoxanthin) at least 7 days before Visit 2 ;
- are women who are pregnant, breastfeeding, or wish to become pregnant during the study;
- have an untreated psychotic or major depressive disorder or any history of cognitive deficit;
- have an uncontrolled hypertension/diabetes/thyroid/heart disease disease, cancer etc.);
- have a significant neurological disease;
- have planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study;
- have a history within previous 12 months of alcohol or substance abuse;
- have known allergy to any of the ingredients in the supplement product
- are not willing to supply their own gaming system and/or game
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Microphytlead
- Texas A&M Universitycollaborator
Study Sites (1)
Exercise & Sport Nutrition Lab
College Station, Texas, 77843-4253, United States
Related Publications (1)
Leonard M, Maury J, Dickerson B, Gonzalez DE, Kendra J, Jenkins V, Nottingham K, Yoo C, Xing D, Ko J, Pradelles R, Faries M, Kephart W, Sowinski R, Rasmussen CJ, Kreider RB. Effects of Dietary Supplementation of a Microalgae Extract Containing Fucoxanthin Combined with Guarana on Cognitive Function and Gaming Performance. Nutrients. 2023 Apr 15;15(8):1918. doi: 10.3390/nu15081918.
PMID: 37111136DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Kreider, Professor
Texas A&M University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2021
First Posted
April 21, 2021
Study Start
April 26, 2021
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
September 23, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share